References
- 1. Food and Drug Administration of Thailand. National list of essential medicine. [cited Dec 12 2009]. Available from: http://www.thaifda.com/ed2547/.
- 2. Homnick DN, Marks JH, Hare KL, Bonnema SK. Long-term trial of cyproheptadine as an appetite stimulant in cystic fibrosis. Pediatr Pulmonol. 2005; 40: 251-6.
- 3. Bruera E. Current pharmacological management of anorexia in cancer patients. Oncology (Williston Park). 1992; 6:125-30; discussion: 32, 37.
- 4. Jatoi A, Loprinzi CL. An update: cancer-associated anorexia as a treatment target. Curr Opin Clin Nutr Metab Care. 2001; 4:179-82.10.1097/00075197-200105000-00002
- 5. Mattox TW. Treatment of unintentional weight loss in patients with cancer. Nutr Clin Pract. 2005; 20: 400-10.
- 6. Mao X, Liang SB, Hurren R, Gronda M, Chow S, Xu GW, et al. Cyproheptadine displays preclinical activity in myeloma and leukemia. Blood. 2008; 112: 760-9.
- 7. Powers PS, Santana C. Available pharmacological treatments for anorexia nervosa. Expert Opin Pharmacother. 2004; 5:2287-92.
- 8. Balog DL, Epstein ME, Amodio-Groton MI. HIV wasting syndrome: treatment update. Ann Pharmacother. 1998; 32:446-58.
- 9. Aguilera A, Selgas R, Diez JJ, Bajo MA, Codoceo R, Alvarez V. Anorexia in end-stage renal disease: pathophysiology and treatment. Expert Opin Pharmacother. 2001; 2:1825-38.
- 10. World Health Organization. Physical status: the use and interpretation of anthropometry. Report of a WHO expert committee. Technical Report Series No. 854. Geneva:WHO, 1995.
- 11. Mahachoklertwattana P, Wanasuwankul S, Poomthavorn P, Choubtum L, Sriphrapradang A. Shortterm cyproheptadine therapy in underweight children: effects on growth and serum insulin-like growth factor- I. J Pediatr Endocrinol Metab. 2009; 22:425-32.
- 12. Kaplowitz PB, Jennings S. Enhancement of linear growth and weight gain by cyproheptadine in children with hypopituitarism receiving growth hormone therapy. J Pediatr. 1987; 110:140-3.
- 13. Couluris M, Mayer JL, Freyer DR, Sandler E, Xu P, Krischer JP. The effect of cyproheptadine hydrochloride (periactin) and megestrol acetate (megace) on weight in children with cancer/treatmentrelated cachexia. J Pediatr Hematol Oncol. 2008; 30: 791-7.10.1097/MPH.0b013e3181864a5e
- 14. Heyward VH. Practical body composition assessment for children, adults, and older adults. Int J Sport Nutr. 1998; 8:285-307.
- 15. Sung RY, So HK, Choi KC, Li AM, Yin J, Nelson EA. Body fat measured by bioelectrical impedance in Hong Kong Chinese children. Hong Kong Med J. 2009; 15:110-7.
- 16. Gharib NM, Shah P. Anthropometry and body composition of school children in Bahrain. Ann Saudi Med. 2009; 29:258-69.10.4103/0256-4947.55309
- 17. Chakrabarty AS, Pillai RV, Anand BK, Singh B. Effect of cyproheptadine on the electrical activity of the hypothalamic feeding centres. Brain Res. 1967; 6: 561-9.10.1016/0006-8993(67)90066-2
- 18. Montgomery AM, Fletcher PJ, Burton MJ. Behavioural and pharmacological investigations of 5-HT hypophagia and hyperdipsia. Pharmacol Biochem Behav. 1986; 25:23-8.
- 19. Sakata T, Ookuma K, Fukagawa K, Fujimoto K, Yoshimatsu H, Shiraishi T, et al. Blockade of the histamine H1-receptor in the rat ventromedial hypothalamus and feeding elicitation. Brain Res. 1988; 441:403-7.
- 20. Baxter MG, Miller AA, Soroko FE. The effect of cyproheptadine on food consumption in the fasted rat. Br J Pharmacol. 1970; 39:229P-30P.
- 21. Ghosh MN, Parvathy S. The effect of cyproheptadine on water and food intake and on body weight in the fasted adult and weanling rats. Br J Pharmacol. 1973; 48:328P-9P.
- 22. Rahman KM. Appetite stimulation and weight gain with cyproheptadine (periactin) in tuberculosis patients (double-blind clinical study). Med J Malaysia. 1975; 29:270-4.
- 23. Silverstone T, Schuyler D. The effect of cyproheptadine on hunger, calorie intake and body weight in man. Psychopharmacologia. 1975; 40:335-40.10.1007/BF00421472
- 24. Toth K, Szonyi A. The appetite stimulating and weight gain promoting effect of peritol (cyproheptadine) examined on a great number of outpatients. Ther Hung. 1976; 24:24-32.
- 25. Ambrosini GL, de Klerk NH, O’Sullivan TA, Beilin LJ, Oddy WH. The reliability of a food frequency questionnaire for use among adolescents. Eur J Clin Nutr. 2009; 63:1251-9.
- 26. Collett-Solberg PF, Misra M. The role of recombinant human insulin-like growth factor-I in treating children with short stature. J Clin Endocrinol Metab. 2008; 93: 10-8.
- 27. Lemaire P, Brauner N, Hammer P, Trivin C, Souberbielle JC, Brauner R. Improved screening for growth hormone deficiency using logical analysis data. Med Sci Monit. 2009; 15:MT5-10.
- 28. Spiliotis BE, Alexandrides TK, Karystianos C, Vassilakos P, Zadik Z, Nikolakopoulou NM, et al. The insulin-like growth factor-I (IGF-I) generation test as an indicator of growth hormone status. Hormones (Athens). 2009; 8:117-28.